Fraunhofer wins contract for anthrax vaccine work

Fraunhofer to work on anthrax vaccine

9:02 PM,
Dec. 4, 2012

Plants being cultivated at the Fraunhofer Center for Molecular Biotechnology facility in Newark, DE. Fraunhofer could receive up to $9.9 million in the coming years for its work on improving the vaccine against anthrax

Written by

A Newark-based bio-science research center has secured $1.76 million in government funding for the development of a cheaper and more effective anthrax vaccine.

If certain targets are met, the Fraunhofer Center for Molecular Biotechnology could receive up to $9.9 million in the coming years for its work on improving the vaccine against anthrax, a deadly bacterial infection considered a potential terrorist weapon.

The contract awarded by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, is a significant one for the Fraunhofer ...